Navigation Links
ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results
Date:2/24/2009

2007 ---- ---- Net cash provided by operating activities $91,437 $122,867 Net cash provided by (used in) Investing activities 15,440 (216,176) Net cash (used in)/provided by financing activities (10,070) 221,471 Selected Consolidated Balance Sheet Data December 31, December 31, (in thousands) 2008 2007 ---- ---- Assets Current assets: Cash and cash equivalents $275,839 $179,691 Short-term investments - 404,637 Deferred income taxes 26,785 7,983 Total current assets 356,445 622,773 Intangible assets, net 639,693 122,502 Goodwill 34,787 - Deferred income taxes 91,757 12,312 Total assets 1,147,574 776,066 Liabilities and Stockholders' Equity Total current liabilities $51,086 $28,370 Deferred tax liabilities 181,392 - Long-term debt 250,000 250,000 Total liabilities 486,550 279,503 Total stockholders' equity 661,024 496,563 Total liabilities and stockholders' equity 1,147,574 776,066


'/>"/>
SOURCE ViroPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. ViroPharma to Present at Three November Healthcare Conferences
2. ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
3. ViroPharma to Release 2008 Third Quarter Financial Results on October 29, 2008
4. ViroPharma to Present at Three October Healthcare Conferences
5. ViroPharma to Present at Three September Healthcare Conferences
6. ViroPharma To Acquire Lev Pharmaceuticals
7. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
8. Viropharma Comments On Upcoming FDA Advisory Committee Meeting
9. ViroPharma to Present at Two Upcoming Healthcare Conferences
10. ViroPharma to Present at the Seventh Annual JMP Securities Research Conference
11. ViroPharma to Present at the Cowen & Company 28th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014  RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) ... has received a Canadian Patent for Inhibition or ... patent includes claims using thymosin beta 4, various ... for these purposes.  The patent will expire in ... ( www.regenerx.com ) RegeneRx is ...
(Date:9/30/2014)... 30, 2014 Fast, semi-automatic ... chemistry in documents ChemAxon , ... consulting services for life science research, launches ChemCurator, ... Markush structures from documents. Markush structures ... however generating and understanding Markush structures is a ...
(Date:9/30/2014)... 2014 OriginOil Inc. (OTC/QB: OOIL), developer ... to clean up large quantities of water, announced today ... reported on the launch of the company's CLEAN-FRACâ„¢ industrial ... by partner STW Resources . , Immediately upon ... day (bpd) and achieved a 99.8% reduction in Turbidity ...
(Date:9/30/2014)... Md., Sept. 30, 2014 BioHealth Innovation, ... commercializing market-relevant biohealth innovations and increasing access to early-stage ... today that venture capitalist, Tania Fernandez , Ph.D., ... Dr. Fernandez will be a member of the management ... provide up to $50 million in seed and early-stage ...
Breaking Biology Technology:RegeneRx Receives Canadian Patent for Inhibition or Reversal of Skin Aging 2ChemAxon Introduces ChemCurator for Chemical Information Extraction and Markush Structure Creation 2OriginOil, Inc. Report to Shareholders: Blue Gold in West Texas 2Seasoned Life Sciences Venture Capitalist Tania Fernandez Joins BHI to Help Manage New BioHealth Gap Fund 2
... LOS ALAMOS, New Mexico, December 13, 2007In collaboration ... Alamos, an international team of researchers has, for ... formation of mysterious metallic puddles that facilitate the ... electrically conducting one. , The research may lead ...
... SAN DIEGO, Dec. 13 Neurocrine Biosciences,Inc. (Nasdaq: ... at its San Diego campus, as a part of ... and associated costs,and expenses after the setback on indiplon. ... "It is with great disappointment that we have to ...
... GRENOBLE France, December 13 ,STALLERGENES S.A and Protein,eXpert ... developing and pharmaceutically producing mites,recombinant allergens(1)., The ... programme for a recombinant protein treatment for sublingual,desensitisation ... up of the recombinant allergens Der p 1 ...
Cached Biology Technology:Collaboration yields 'the right glasses' for observing mystery behavior in electrons 2Collaboration yields 'the right glasses' for observing mystery behavior in electrons 3Neurocrine Announces Work Force Restructuring 2Neurocrine Announces Work Force Restructuring 3STALLERGENES and Protein' eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens 2STALLERGENES and Protein' eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens 3
(Date:9/30/2014)... threats in today,s ocean. From overfishing and pollution ... ecosystems are disappearing at unprecedented rates around the ... surrounding the island of Moorea in French Polynesia ... coral guard-crabs. New research from the National Museum ... McKeon and the museum,s predoctoral fellow Jenna Moore ...
(Date:9/29/2014)... the exposure to tar tended to be lower for ... Similarly, exposure to nicotine tended to be lower. , ... in several countries around the world. Previous studies have ... the smoke of these cigarettes are lower than those ... in the smoke are not necessarily linked to a ...
(Date:9/29/2014)... in school? According to a new Food and Brand ... meals can increase participation in the National School Lunch ... of vegetables by 16%! , Chefs Move to Schools ... pairs chefs with schools in order to provide nutrition ... food service workers. , A CMTS event was held ...
Breaking Biology News(10 mins):Smithsonian scientists discover coral's best defender against an army of sea stars 2Slim cigarette smokers not exposed to more harmful chemicals 2Chefs move to schools can increase school meal participation and vegetable intake among students 2
... , This release is available in German . ... chemically fix, stain or cut cells in order to study them. ... environment. The new method delivers an immediate 3-D image, thereby closing ... a high-resolution 3-D image of the entire cell in one step. ...
... Mass. Although people infected with HIV produce many antibodies ... are strangely ineffective at fighting the disease. A new study ... don,t work: they target the protein in a form it ... it,s too late, report researchers at Children,s Hospital Boston and ...
... Madrid, Friday November 19th, 2010. It is estimated ... / 10,000 people- affect about 6% of the European population. ... risk of having a newborn with a severe syndrome of ... affected by one of these diseases, being the most common ...
Cached Biology News:New microscope reveals ultrastructure of cells 2Designing more effective anti-HIV antibodies 2Designing more effective anti-HIV antibodies 3Spain is leading the fight against rare anemias in Europe 2